Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“The Düsseldorf Patient” has been off HIV meds only since November 2018, so it is much too early to determine whether he has been cured.
Timothy Brown may have company after a man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.
A new study analyzes nuances in a cohort of six people who also received stem cell transplants for blood cancers.
Today, with better understanding of the complex task at hand, cure researchers are investigating multiple avenues and taking the long view.
Aside from taking antiretrovirals, quitting smoking is the number one way people with HIV can lower their risk of illness and death.
Cancer and HIV are invaders that the immune system fails to detect, and the similarities don’t end there.
Another man living with HIV attempts to stay off antiretrovirals after a bone marrow transplant to treat his leukemia.
In contrast to the only person cured of HIV, this man did not have a donor with a genetic abnormality conferring HIV resistance.
So why is he taking meds every day?
Immunotherapy and an HIV vaccine are among the first round of grants from Fred Hutch’s Evergreen Fund.
A second man may have been cured of HIV following treatment for leukemia and a stem-cell transplant.
A 12-year-old boy with HIV and leukemia has died after undergoing the first-ever attempt to cure both diseases with a cord-blood transplant.
She is the first child to have succeeded in using the immune system over the long term to fight cancer.
The short answer: Yes, Timothy Brown, otherwise known as “the Berlin Patient,” remains cured of HIV.
Genetically modified T cells—notably CD4 and CD8 cells—administered to people living with HIV participating in one of three clinic...
Participating in clinical trials can bolster your health—and that of the whole community.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.